JP2019532674A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019532674A5 JP2019532674A5 JP2019540313A JP2019540313A JP2019532674A5 JP 2019532674 A5 JP2019532674 A5 JP 2019532674A5 JP 2019540313 A JP2019540313 A JP 2019540313A JP 2019540313 A JP2019540313 A JP 2019540313A JP 2019532674 A5 JP2019532674 A5 JP 2019532674A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- item
- biologically active
- active fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662406689P | 2016-10-11 | 2016-10-11 | |
| US62/406,689 | 2016-10-11 | ||
| US201662414266P | 2016-10-28 | 2016-10-28 | |
| US62/414,266 | 2016-10-28 | ||
| PCT/US2017/056178 WO2018071565A1 (en) | 2016-10-11 | 2017-10-11 | TCRa HOMING ENDONUCLEASE VARIANTS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019532674A JP2019532674A (ja) | 2019-11-14 |
| JP2019532674A5 true JP2019532674A5 (enExample) | 2020-11-19 |
| JP7104710B2 JP7104710B2 (ja) | 2022-07-21 |
Family
ID=61905974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019540313A Active JP7104710B2 (ja) | 2016-10-11 | 2017-10-11 | ＴＣＲαホーミングエンドヌクレアーゼバリアント |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11591582B2 (enExample) |
| EP (1) | EP3534916A4 (enExample) |
| JP (1) | JP7104710B2 (enExample) |
| KR (1) | KR20190065382A (enExample) |
| CN (1) | CN110036107B (enExample) |
| AU (1) | AU2017342273B2 (enExample) |
| CA (1) | CA3039812A1 (enExample) |
| IL (1) | IL265895A (enExample) |
| MA (1) | MA46717A (enExample) |
| MX (1) | MX2019004156A (enExample) |
| RU (1) | RU2019114035A (enExample) |
| SG (1) | SG11201903230QA (enExample) |
| WO (1) | WO2018071565A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| SG11201901757YA (en) | 2016-09-08 | 2019-03-28 | Bluebird Bio Inc | Pd-1 homing endonuclease variants, compositions, and methods of use |
| SG11201903230QA (en) | 2016-10-11 | 2019-05-30 | Bluebird Bio Inc | TCRa HOMING ENDONUCLEASE VARIANTS |
| US11530395B2 (en) | 2016-10-17 | 2022-12-20 | 2Seventy Bio, Inc. | TGFBetaR2 endonuclease variants, compositions, and methods of use |
| CA3122094A1 (en) | 2018-12-10 | 2020-06-18 | Bluebird Bio, Inc. | Pdcd-1 homing endonuclease variants |
| JP2022513750A (ja) * | 2018-12-10 | 2022-02-09 | ２セブンティ バイオ インコーポレイテッド | ホーミングエンドヌクレアーゼバリアント |
| WO2022140150A1 (en) * | 2020-12-21 | 2022-06-30 | 2Seventy Bio, Inc. | Compositions and methods for site-directed mutagenesis |
| EP4355875A1 (en) | 2021-06-14 | 2024-04-24 | 2seventy bio, Inc. | Single stranded rna purification methods |
| US20250043269A1 (en) | 2021-11-03 | 2025-02-06 | The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glad | Precise Genome Editing Using Retrons |
| WO2023141602A2 (en) | 2022-01-21 | 2023-07-27 | Renagade Therapeutics Management Inc. | Engineered retrons and methods of use |
| AU2023329392A1 (en) | 2022-08-25 | 2025-02-27 | Renagade Therapeutics Management Inc. | Engineered retrons and methods of use |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US4873192A (en) | 1987-02-17 | 1989-10-10 | The United States Of America As Represented By The Department Of Health And Human Services | Process for site specific mutagenesis without phenotypic selection |
| AU649074B2 (en) | 1990-10-12 | 1994-05-12 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Modified ribozymes |
| US5652094A (en) | 1992-01-31 | 1997-07-29 | University Of Montreal | Nucleozymes |
| US20020119158A1 (en) * | 1998-12-17 | 2002-08-29 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| US6692736B2 (en) | 2000-03-24 | 2004-02-17 | Cell Genesys, Inc. | Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| PT1421115E (pt) * | 2001-08-31 | 2005-07-29 | Avidex Ltd | Receptor de celulas t soluvel |
| KR100415267B1 (ko) * | 2002-02-19 | 2004-01-16 | 오광수 | 2단 발효법에 의한 고 순도 멸치액젓 및 그 제조방법 |
| EP1413626A1 (en) * | 2002-10-23 | 2004-04-28 | Vicuron Pharmaceuticals, Inc. | Genes and proteins for the biosynthesis of the glycopeptide antibiotic A40926 |
| US20110239315A1 (en) | 2009-01-12 | 2011-09-29 | Ulla Bonas | Modular dna-binding domains and methods of use |
| US8956828B2 (en) | 2009-11-10 | 2015-02-17 | Sangamo Biosciences, Inc. | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases |
| WO2011156430A2 (en) | 2010-06-07 | 2011-12-15 | Fred Hutchinson Cancer Research Center | Generation and expression of engineered i-onui endonuclease and its homologues and uses thereof |
| US9034813B2 (en) * | 2010-09-17 | 2015-05-19 | Ecolab Usa Inc. | High performance low viscoelasticity foaming detergent compositions employing extended chain anionic surfactants |
| BR112013030652A2 (pt) * | 2011-06-10 | 2016-12-13 | Basf Plant Science Co Gmbh | polinucleotídeo que codifica um polipeptídeo, molécula de ácido nucleico, vetor, organismo não humano, polipeptídeo e método para introduzir um ácido nucleico de interesse em um genoma de um organismo não humano |
| US8450107B1 (en) * | 2011-11-30 | 2013-05-28 | The Broad Institute Inc. | Nucleotide-specific recognition sequences for designer TAL effectors |
| SG10201806573TA (en) | 2012-05-25 | 2018-09-27 | Cellectis | Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy |
| CA2913872C (en) * | 2013-05-31 | 2022-01-18 | Cellectis | A laglidadg homing endonuclease cleaving the t-cell receptor alpha gene and uses thereof |
| SG11201903230QA (en) | 2016-10-11 | 2019-05-30 | Bluebird Bio Inc | TCRa HOMING ENDONUCLEASE VARIANTS |
-
2017
- 2017-10-11 SG SG11201903230QA patent/SG11201903230QA/en unknown
- 2017-10-11 RU RU2019114035A patent/RU2019114035A/ru not_active Application Discontinuation
- 2017-10-11 MA MA046717A patent/MA46717A/fr unknown
- 2017-10-11 MX MX2019004156A patent/MX2019004156A/es unknown
- 2017-10-11 CA CA3039812A patent/CA3039812A1/en not_active Abandoned
- 2017-10-11 EP EP17859441.2A patent/EP3534916A4/en active Pending
- 2017-10-11 KR KR1020197013234A patent/KR20190065382A/ko not_active Withdrawn
- 2017-10-11 CN CN201780074992.4A patent/CN110036107B/zh active Active
- 2017-10-11 WO PCT/US2017/056178 patent/WO2018071565A1/en not_active Ceased
- 2017-10-11 JP JP2019540313A patent/JP7104710B2/ja active Active
- 2017-10-11 AU AU2017342273A patent/AU2017342273B2/en active Active
- 2017-10-11 US US16/340,257 patent/US11591582B2/en active Active
-
2019
- 2019-04-08 IL IL265895A patent/IL265895A/en unknown
-
2023
- 2023-02-24 US US18/174,165 patent/US12264343B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2019114035A (ru) | ВАРИАНТЫ ХОМИНГ-ЭНДОНУКЛЕАЗЫ ТКРα | |
| JP7649370B2 (ja) | 抗ｋｒａｓ－ｇ１２ｄ ｔ細胞受容体 | |
| JP7461445B2 (ja) | Ｈｌａ－ｃｗ８拘束性の変異ｋｒａｓを認識するｔ細胞受容体 | |
| JP7026161B2 (ja) | 免疫調節性融合タンパク質およびその使用 | |
| Marshall et al. | NKG2C/E marks the unique cytotoxic CD4 T cell subset, ThCTL, generated by influenza infection | |
| JP2022532557A5 (enExample) | ||
| KR20200065026A (ko) | P53 암-특이적 돌연변이에 대한 항원 특이성을 갖는 t 세포를 단리하는 방법 | |
| JP2021505201A5 (enExample) | ||
| JP2019512242A (ja) | がんに対する免疫療法で使用するための形質移入ｔ細胞およびｔ細胞受容体 | |
| JP2019506175A5 (enExample) | ||
| WO2008042814A2 (en) | Mart-1 t cell receptors | |
| JP2021526860A5 (enExample) | ||
| CA3110878A1 (en) | T cell modification | |
| US20190135893A1 (en) | Antigen-specific helper t-cell receptor genes | |
| JP2022510481A5 (enExample) | ||
| IL299491A (en) | Methods and compositions for editing the b2m locus in b cells | |
| JP2016511221A5 (enExample) | ||
| Jeong et al. | IFITM3 is upregulated characteristically in IL-15–mediated bystander-activated CD8+ T cells during influenza infection | |
| Nair et al. | Antiretroviral restriction factors in mice | |
| Graham et al. | Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon‐γ? | |
| JP2017515795A5 (enExample) | ||
| US20230272431A1 (en) | Methods and compositions for editing the b2m locus in b cells | |
| JP2009515534A (ja) | Ｈｃｖ−反応性ｔ細胞受容体 | |
| Vila De Mucha | Transcriptional regulation of tumour infiltrating cytotoxic CD4+ T cell differentiation | |
| Zhao | Searching for Modulators of CD8+ T Cell Exhaustion |